BLACK DIAMOND THERAPEUTICS I
BDTX·09203E105·US·Common Stock·Healthcare - Biotechnology-13D/G
BDTX (BLACK DIAMOND THERAPEUTICS I) is held by 63 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($3.5M), DIMENSIONAL FUND ADVISORS LP ($2.8M), BlackRock, Inc. ($2.4M). Net institutional sentiment: Mixed.
63
Holders
Avg rating(14 Elite)
$32.6M
Total Value
50% (69)
Fund Consensus
30 buying - 30 selling
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.7.0%Jul 8, 2026
ActivistVPVestal Point Capital, LP1.5%Feb 17, 2026
ActivistBBBB Biotech AG4.8%Mar 21, 2025
InsiderBVBIOTECH GROWTH N VSell $2.1MMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $583KMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $2.3MMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $4.0MMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $837KMar 19, 2025
InsiderBVBIOTECH GROWTH N VSell $1.1MMar 19, 2025
13F: Insider & Congress:
Showing 1-20 of 69
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer